Optimizing Treatment Selection for Patients with FLT3-ITD AML
Discussion centered around optimal strategies to effectively treat, and improve outcomes for, patients with FLT3-ITD AML.
Read More
Standard Approach to Treatment for Fit Patients with Newly Diagnosed AML
Recommendations for community oncologists concerning the treatment of fit patients diagnosed with AML.
Read More
Clinical Insights Concerning Molecular Testing in Patients Diagnosed with Acute Myeloid Leukemia
Eunice S. Wang, MD opens a discussion with other panelists concerning the benefits of germline testing in AML, NCCN guidelines for molecular testing, and how molecular testing in AML is advancing over time.
Read More
An Introduction to Biomarker Testing in Acute Myeloid Leukemia
Experienced clinicians highlight the role of biomarker testing in AML for optimal patient care and treatment selection.
Read More
An Overview of Incidence, Diagnosis, and Subtype Classification in Acute Myeloid Leukemia
Moderator Naval G. Daver, MD introduces expert panelists and leads an overview of Acute Myeloid Leukemia, focusing on the importance of timely diagnosis and risk assessment for patients with AML.
Read More